Pathophysiology of Parkinson's disease
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
Pathophysiology of Parkinson's disease | |
---|---|
![]() | |
Synonyms | N/A |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Tremor, bradykinesia, rigidity, postural instability |
Complications | Dementia, depression, anxiety |
Onset | Typically after age 60 |
Duration | Chronic, progressive |
Types | N/A |
Causes | Neurodegeneration of dopaminergic neurons in the substantia nigra |
Risks | Age, genetic factors, environmental factors |
Diagnosis | Clinical evaluation, neurological examination, imaging studies |
Differential diagnosis | Essential tremor, multiple system atrophy, progressive supranuclear palsy |
Prevention | N/A |
Treatment | Levodopa, dopamine agonists, MAO-B inhibitors, deep brain stimulation |
Medication | N/A |
Prognosis | Progressive worsening over time |
Frequency | Affects approximately 1% of people over 60 |
Deaths | N/A |
The pathophysiology of Parkinson's disease (PD) is complex and involves multiple pathways and neurotransmitter systems. At its core, PD is characterized by the progressive loss of dopamine-producing neurons in the substantia nigra, a region of the midbrain. This article explores the key aspects of the pathophysiology of Parkinson's disease, including its genetic and environmental risk factors, the role of alpha-synuclein, and the impact on neural circuits.
Genetic and Environmental Factors
Several genetic and environmental factors have been identified that contribute to the development of PD. Genetic mutations in genes such as SNCA (which encodes alpha-synuclein), PARK2 (parkin), PINK1 (PTEN-induced kinase 1), and LRRK2 (leucine-rich repeat kinase 2) have been linked to familial forms of the disease. On the environmental side, exposure to certain pesticides and heavy metals has been associated with an increased risk of PD.
Alpha-Synuclein and Lewy Bodies
A hallmark of PD pathology is the accumulation of alpha-synuclein, a presynaptic neuronal protein, into aggregates known as Lewy bodies. These aggregates are toxic to cells and lead to neuronal death. The exact mechanism by which alpha-synuclein aggregates cause cell death is not fully understood but is believed to involve disruptions in cellular processes such as mitochondrial function and protein degradation pathways.
Dopaminergic Neuron Loss
The loss of dopaminergic neurons in the substantia nigra leads to a decrease in dopamine levels in the striatum, a critical component of the motor circuit. Dopamine is a neurotransmitter that plays a key role in regulating movement, and its deficiency in PD results in the characteristic motor symptoms of the disease, including bradykinesia (slowness of movement), rigidity, and tremor.
Impact on Neural Circuits
The reduction in striatal dopamine disrupts the balance of activity in the direct and indirect pathways of the basal ganglia, leading to increased inhibitory output from the basal ganglia to the thalamus and a consequent reduction in excitatory input to the motor cortex. This imbalance contributes to the motor symptoms of PD.
Non-motor Symptoms
In addition to motor symptoms, PD is associated with a range of non-motor symptoms, including olfactory dysfunction, sleep disturbances, autonomic dysfunction, cognitive impairment, and mood disorders. These symptoms are thought to result from the involvement of other neurotransmitter systems and brain regions outside the basal ganglia, including the olfactory bulb, dorsal motor nucleus of the vagus, and the cortex.
Neuroinflammation
Recent research has highlighted the role of neuroinflammation in the pathophysiology of PD. Activation of microglia, the resident immune cells of the brain, and the release of inflammatory mediators can contribute to neuronal death and disease progression.
Conclusion
The pathophysiology of Parkinson's disease is multifaceted, involving genetic and environmental factors, the accumulation of alpha-synuclein into Lewy bodies, loss of dopaminergic neurons, and disruptions in neural circuits. Understanding these mechanisms is crucial for developing targeted therapies for PD.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD